Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Stomach Neoplasms 1Solid Tumors 1Solid Tumor, Adult 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 6Proton Therapy 3spartalizumab 2Rosuvastatin Calcium 2Paclitaxel 2Immune Checkpoint Inhibitors 2Cetuximab 2toripalimab 1sotorasib 1peposertib 1osimertinib 1necitumumab 1mirdametinib 1leronlimab 1apatinib 1amivantamab 1abemaciclib 1Valganciclovir 1Trastuzumab 1Therapeutics 1Rifampin 1Radiotherapy 1PankoMab-GEX 1Panitumumab 1Midazolam 1Metformin 1MEK inhibitor I 1Jupiter 1JPT1 protein, human 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Solid Tumor, Adult × amivantamab × Clear all
NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Kumquat Biosciences Inc.

Phase 1 Recruiting
100 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡